| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3852042 | American Journal of Kidney Diseases | 2007 | 10 Pages | 
Abstract
												In patients with advanced CKD, atorvastatin is associated with improvement in dyslipidemia and small-artery stiffness, but not endothelial function. Gemfibrozil improves dyslipidemia, but has no effect on arterial function.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Nephrology
												
											Authors
												Gursharan MBBCh, FRACP, PhD, Ashley MBBS, FRACP, Dick PhD, Gerald MD, PhD, FRCP, FRACP, 
											